2‐(1,3‐Dithian‐2‐yl)benzaldehyde and N‐{2‐[2‐(1,3‐dioxan‐2‐yl)phenoxy]­ethyl}phthalimide

The crystal structures of two elaborated‐porphyrin precursors have been determined. In the crystalline state, 2‐(1,3‐di­thian‐2‐yl)­benz­aldehyde, C₁₁H₁₂OS₂, has its di­thiane ring in a slightly distorted chair conformation. The mol­ecules pack in anti‐parallel chains. N‐{2‐[2‐(1,3‐Dioxan‐2‐yl)­phenoxy]­ethyl}­phthal­imide, C₂₀H₁₉NO₅, is in a folded conformation. The dihedral angle between the phthal­imide and phenyl planes is 80.07 (3)°. In the crystalline states, mol­ecules stack on top of one another.     

Synthesis of 5‐[2‐(guanin‐9‐yl)‐ and 5‐[2‐(2‐aminopurin‐9‐yl)ethyl]‐2‐D‐ribo‐(1,2′,3′,4′‐tetrahydroxybutyl)‐1,3‐dioxane

Stereoselective synthesis of 5‐[2‐(guanin‐9‐yl)‐ and 5‐[2‐(2‐aminopurin‐9‐yl)ethyl]‐2‐D‐ribo‐(1′,2′,3′,4′‐tetrahydroxybutyl)‐1,3‐dioxane, 2‐5, as potential prodrugs of penciclovir, has been accomplished in six steps from readily available 2,3,4,5‐tetra‐O‐acetyl‐aldehydo‐D‐ribose ( 6 ) and the 1,3‐diol 7 . It has been demonstrated that the use of boron trifluoride diethyl etherate (BF₃·Et₂O) in dichloromethane along with excess anhydrous copper(II) sulfate was crucial for the efficient formation of cyclic acetal 8 . In addition, the chromatographic separation of cis and trans isomers of the cyclic acetal at the bromide stage 10 was feasible, which was requisite for the successful stereoselective synthesis of the ribosyl derivatives 2–5 .     

Ethyl 5‐methyl‐4‐(2,5,5‐tri­methyl‐1,3‐dioxan‐2‐yl)­isoxazole‐3‐carboxyl­ate

The title compound, C₁₄H₂₁NO₅, possesses an isoxazolyl group in the axial position of the 1,3‐dioxanyl ring. The two rings are rotated about the bond joining them such that the two C(methyl)—C(dioxanyl)—C—C torsion angles are 92.1 (2) and ?84.1 (2)°. In this conformation, neither the methyl nor ethoxy­carbonyl substituents on the isoxazole are presented towards the dioxanyl chair.     

2,2′,4,4′,6,6′‐Hexa­methyl‐4,4′‐bi­[4H‐pyran­yl]

The title mol­ecule, C₁₆H₂₂O₂, reveals C_i point symmetry in the crystal structure. The structure was disordered. The pyran ring is not planar; the O atom lies significantly out of the least‐squares plane (ten times the r.m.s. deviation of all six atoms).     

2‐[2‐(Pyrrolidin‐2‐yl)propan‐2‐yl]‐1H‐pyrrole and its amide derivative 1‐{2‐[2‐(1H‐pyrrol‐2‐yl)propan‐2‐yl]pyrrolidin‐1‐yl}ethanone

In the title compounds, C₁₁H₁₈N₂, (II), and C₁₃H₂₀N₂O, (III), the pyrrolidine rings have twist conformations. Compound (II) crystallizes with two independent molecules (A and B) in the asymmetric unit. The mean planes of the pyrrole and pyrrolidine rings are inclined to one another by 89.99 (11) and 89.35 (10)° in molecules A and B, respectively. In (III), the amide derivative of (II), the same dihedral angle is much smaller, at only 13.42 (10)°. In the crystal structure of (II), the individual molecules are linked via N—H...N hydrogen bonds to form inversion dimers, each with an R²₂(12) graph‐set motif. In the crystal structure of (III), the molecules are linked via N—H...O hydrogen bonds to form inversion dimers with an R²₂(16) graph‐set motif.     

Racemic (1,4‐dioxan‐2‐yl)diphenylmethanol

The title compound, C₁₇H₁₈O₃, prepared by microwave irradiation of benzophenone and dioxane, crystallizes in a racemic mixture that forms one‐dimensional chains via strong hydrogen bonding of the hydroxy group to the adjacent symmetry‐generated 1,4‐dioxan‐2‐yl group; the O—H...O distance is 1.99 (3) Å and the O—H...O angle is 160 (2)°.     

2,2‐Dimethyl‐5‐nitroso‐1,3‐dioxan‐5‐yl benzoate, 2,2‐dimethyl‐5‐nitroso‐1,3‐dioxan‐5‐yl 4‐chlorobenzoate and 5‐nitroso‐1,3‐dioxan‐5‐yl 4‐chlorobenzoate

The crystal structures of 2,2‐dimethyl‐5‐nitroso‐1,3‐dioxan‐5‐yl benzoate, C₁₃H₁₅NO₅, (I), 2,2‐dimethyl‐5‐nitroso‐1,3‐dioxan‐5‐yl 4‐chlorobenzoate, C₁₃H₁₄ClNO₅, (II), and 5‐nitroso‐1,3‐dioxan‐5‐yl 4‐chlorobenzoate, C₁₁H₁₁NO₅, (III), have been determined in order to gain insight into the conformational preference of α‐benzoyloxynitroso. Unfavourable 1,3‐diaxial interactions force (I) and (II) to crystallize in the 2,5 twist‐boat conformation, whereas compound (III), lacking this destabilizing interaction, crystallizes in the chair conformation.     

1,1′‐Di(hydrazinocarbonylmethyl)‐2,2′‐biimidazole monohydrate and 1,1′‐di[2‐(hydrazinocarbonyl)ethyl]‐2,2′‐bi­imidazole

The crystal structures of the title compounds, alternatively called 2,2′‐(2,2′‐bi­imid­azole‐1,1′‐diyl)­diaceto­hydra­zide monohydrate, C₁₀H₁₄N₈O₂·H₂O, (I), and 3,3′‐(2,2′‐bi­imid­azole‐1,1′‐diyl)­dipropion­o­hydra­zide, C₁₂H₁₈N₈O₂, (II), respectively, have been determined. The mol­ecules consist of half‐mol­ecule asymmetric units related by a twofold rotation in (I) and by a center of inversion in (II). The imidazole rings of both mol­ecules crystallize in a nearly coplanar fashion [dihedral angles of 5.91 (3) and 0.0 (1)° for (I) and (II), respectively]. Both planar hy­dra­zinocarbonylalkyl substituents are essentially planar and assume the E orientation.     

[2‐(Imidazol‐4‐yl)ethylamine]{[2‐(imidazol‐4‐yl)ethyl][(1‐methylimidazol‐2‐yl)methyl]amine}copper(II) diperchlorate

In the title mononuclear complex, [Cu(C₅H₉N₃)(C₁₀H₁₅N₅)](ClO₄)₂, the Cu^II centre is surrounded by two N‐donor ligands, which impose a square‐pyramidal environment on the metal. The new tridentate ligand [2‐(imidazol‐4‐yl)­ethyl]­[(1‐methyl­imidazol‐2‐yl)­methyl]­amine (HISMIMA) lies in the basal plane, while the hist­amine ligand occupies the apical and one of the basal positions around the Cu^II ion.     

(+)‐3‐{(4S,5S)‐5‐[1,1‐Di­methyl‐2‐(phenyl­thio)­ethyl]‐2,2‐di­methyl‐1,3‐dioxolan‐4‐yl}prop‐2‐yn‐1‐ol

The absolute configuration was determined for the title compound, (+)‐C₁₈H₂₄O₃S, (I), which was prepared in a synthetic study on the natural products, bryostatins.     

(Z)‐5‐[4‐(Dimethylamino)benzylidene]‐2‐(piperidin‐1‐yl)‐1,3‐thiazolidin‐4(5H)‐one

The molecules of the title compound, C₁₇H₂₁N₃OS, are characterized by a wide C—C—C angle at the methine C atom linking the aryl and thiazolidine rings, associated with a short repulsive intramolecular S...H contact between atoms in these two rings. A single piperidine–arene C—H...π hydrogen bond links pairs of molecules into centrosymmetric dimers.     

Bis­[2‐(2‐hydroxy­phenoxy)­ethyl] ether methanol solvate

The title compound, 2,2′‐(3‐oxa­pentane‐1,5‐diyl­dioxy)­diphenol, crystallizes as a methanol solvate, C₁₆H₁₈O₅·CH₄O. The methanol mol­ecule, roughly perpendicular to the mean plane of the polyether molecule, is hydrogen bonded to the two polyether OH groups and to the central ether O atom. Possible C—H?π intermolecular interactions are present.     

Tris­[2‐(benzoyl­amino)­ethyl]­amine

Tris­[2‐(benzoyl­amino)­ethyl]­amine [alternatively, N,N′,N′′‐(nitrilo­tri­ethyl)­tri­benz­amide], C₂₇H₃₀N₄O₃, adopts a folded structure, forming a symmetrical cavity with an average depth of 7.3 Å and width ranging from 4.1–4.4 Å. The folded structure is a result of one intramolecular N—H?O hydrogen bond. A linear chain motif along the c axis best describes the extended intermolecular N—H?O hydrogen bonding.     

ZnII and CuII complexes generated from 5‐(pyridin‐4‐yl)‐3‐[2‐(pyridin‐4‐yl)ethyl]‐1,3,4‐oxadiazole‐2(3H)‐thione

A new 1,3,4‐oxadiazole‐containing bispyridyl ligand, namely 5‐(pyridin‐4‐yl)‐3‐[2‐(pyridin‐4‐yl)ethyl]‐1,3,4‐oxadiazole‐2(3H)‐thione (L), has been used to create the novel complexes tetranitratobis{μ‐5‐(pyridin‐4‐yl)‐3‐[2‐(pyridin‐4‐yl)ethyl]‐1,3,4‐oxadiazole‐2(3H)‐thione}zinc(II), [Zn₂(NO₃)₄(C₁₄H₁₂N₄OS)₂], (I), and catena‐poly[[[dinitratocopper(II)]‐bis{μ‐5‐(pyridin‐4‐yl)‐3‐[2‐(pyridin‐4‐yl)ethyl]‐1,3,4‐oxadiazole‐2(3H)‐thione}] nitrate acetonitrile sesquisolvate dichloromethane sesquisolvate], {[Cu(NO₃)(C₁₄H₁₂N₄OS)₂]NO₃·1.5CH₃CN·1.5CH₂Cl₂}_n, (II). Compound (I) presents a distorted rectangular centrosymmetric Zn₂L₂ ring (dimensions 9.56 × 7.06 Å), where each Zn^II centre lies in a {ZnN₂O₄} coordination environment. These binuclear zinc metallocycles are linked into a two‐dimensional network through nonclassical C—H...O hydrogen bonds. The resulting sheets lie parallel to the ac plane. Compound (II), which crystallizes as a nonmerohedral twin, is a coordination polymer with double chains of Cu^II centres linked by bridging L ligands, propagating parallel to the crystallographic a axis. The Cu^II centres adopt a distorted square‐pyramidal CuN₄O coordination environment with apical O atoms. The chains in (II) are interlinked via two kinds of π–π stacking interactions along [01]. In addition, the structure of (II) contains channels parallel to the crystallographic a direction. The guest components in these channels consist of dichloromethane and acetonitrile solvent molecules and uncoordinated nitrate anions.     

Utility of 2‐[4‐(3‐oxobenzo[f]‐2H‐chromen‐2‐yl)‐1,3‐thiazol‐2‐yl]ethanenitrile in heterocyclic synthesis

Pyrazolo[4,3‐d]pyrimidines, pyrazolo[4,3‐d]triazolino[4,3‐a]pyrimidines, 3‐(2‐thiazolyl)thiophenes, thiazolo[3,2‐a]pyridine and pyrazolo[1,5‐a]pyrimidines were synthesized from 2‐[4‐(3‐oxobenzo[f]‐2H‐chromen‐2‐yl)‐1,3‐thiazol‐2‐yl]ethanenitrile. The newly synthesized compounds were elucidated by elemental analysis, spectral data, chemical transformation and alternative synthesis route whenever possible.     

Simultaneous determination of acyclovir,ganciclovir, and (R)‐9‐[4‐hydroxy‐2‐(hydroxymethyl)butyl]guanine in human plasma using high‐performance liquid chromatography

Acyclovir, ganciclovir and (R)‐9‐[4‐hydroxy‐2‐(hydroxymethyl)butyl]guanine are active in vitro against the Epstein–Barr virus (EBV) but their in vivo anti‐EBV activity is not well understood. We developed a novel, sensitive high‐performance liquid chromatography assay with ultraviolet detection for measuring acyclovir, ganciclovir and (R)‐9‐[4‐hydroxy‐2‐(hydroxymethyl)butyl]guanine in human plasma to identify quantitative relationships between in vitro anti‐EBV activity and therapeutic response. Characteristics of the assay include a low plasma volume (200 µL), perchloric acid protein precipitation, use of penciclovir as the internal standard, run times less than 8 min and a 50 ng/mL lower limit of quantification. The within‐ and between‐assay variability is 0.7–4.8 and 1.0–7.9%, respectively. Accuracy for all three drugs ranges from 89.5 to 106.4% for four quality controls (50, 100, 1000 and 10,000 ng/mL). This assay supports pharmacokinetic and pharmacodynamic studies of candidate anti‐EBV drugs in children and adults with EBV infections. Copyright © 2009 John Wiley & Sons, Ltd.     

Ethyl N‐[2‐(hydroxy­acetyl)­phenyl]­carbamate,ethyl N‐[2‐(hydroxy­acetyl)‐4‐iodo­phenyl]­carbamate and ethyl N‐[2‐(hydroxy­acetyl)‐4‐methyl­phenyl]­carbamate

In ethyl N‐[2‐(hydroxy­acetyl)phenyl]carbamate, C₁₁H₁₃NO₄, all of the non‐H atoms lie on a mirror plane in the space group Pnma; the mol­ecules are linked into simple chains by a single C—H⋯O hydrogen bond. The mol­ecules of ethyl N‐[2‐(hydroxy­acetyl)‐4‐iodo­phenyl]carbamate, C₁₁H₁₂INO₄, are linked into sheets by a combination of O—H⋯I and C—H⋯O hydrogen bonds and a dipolar I⋯O contact. Ethyl N‐­[2‐(hydroxy­acetyl)‐4‐methyl­phenyl]carbamate, C₁₂H₁₅NO₄, crystallizes with Z′ = 2 in the space group P; pairs of mol­ecules are weakly linked by an O—H⋯O hydrogen bond and these aggregates are linked into chains by two independent aromatic π–π stacking inter­actions.     

(R)‐4‐(4‐Fluoro­phenyl)‐1‐[2‐hydroxy‐2‐(3‐methyl‐1‐benzo­furan‐2‐yl)­ethyl]­piperazinium chloride propan‐1‐ol solvate

The title compound, C₂₁H₂₄FN₂O₂⁺·Cl⁻·C₃H₈O, is a potential drug designed as a hybrid compound with antihypertensive, antioxidant and β‐adrenolytic activity. The cation contains nearly planar benzo­furan and fluoro­phenyl ring systems, as well as a piperazine ring adopting an almost perfect chair conformation. The benzo­furan and piperazine moieties are connected by an ethyl chain, the moieties forming a dihedral angle of 163.12 (13)°. In the crystal structure, ions and propanol solvent mol­ecules are linked via N—H⋯Cl and O—H⋯Cl bonds into linear (010) chains.     

2‐(6‐Bromo­pyridin‐2‐yl)‐6‐methyl‐[1,3,6,2]­diox­aza­borocane,a new stable (pyridin‐2‐yl)­boronic acid derivative

The crystal structure of the first reported non‐substituted N‐methyl­diox­aza­borocane confirms that the presence of a methyl group attached to the N atom introduces an NB bond length that is longer than that in a simple diox­aza­borocane ring. The presence of more N atoms in the vicinity of the B atom in the title compound [systematic name: 6a‐(6‐bromo­pyridin‐2‐yl)‐3a‐methyl‐2,3,4,5‐tetra­hydro‐1,6‐dioxa‐3a‐aza‐6a‐borapentalene], C₁₀H₁₄BBrN₂O₂, does not modify significantly any structural parameter in the diox­aza­borocane ring. On the other hand, a small asymmetry appears in the bond angles of the pyridine C atom next to the B atom.